Log in to save to my catalogue

The marine‐derived furanone reduces intracellular lipid accumulation in vitro by targeting LXRα and...

The marine‐derived furanone reduces intracellular lipid accumulation in vitro by targeting LXRα and...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7131916

The marine‐derived furanone reduces intracellular lipid accumulation in vitro by targeting LXRα and PPARα

About this item

Full title

The marine‐derived furanone reduces intracellular lipid accumulation in vitro by targeting LXRα and PPARα

Publisher

England: John Wiley & Sons, Inc

Journal title

Journal of cellular and molecular medicine, 2020-03, Vol.24 (6), p.3384-3398

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Recent studies have demonstrated that commercially available lipid‐lowering drugs cause various side effects; therefore, searching for anti‐hyperlipidaemic compounds with lower toxicity is a research hotspot. This study was designed to investigate whether the marine‐derived compound, 5‐hydroxy‐3‐methoxy‐5‐methyl‐4‐butylfuran‐2(5H)‐one, has an anti‐...

Alternative Titles

Full title

The marine‐derived furanone reduces intracellular lipid accumulation in vitro by targeting LXRα and PPARα

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7131916

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7131916

Other Identifiers

ISSN

1582-1838,1582-4934

E-ISSN

1582-4934

DOI

10.1111/jcmm.15012

How to access this item